Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Shocking therapy: new device aims to stop muscle loss in ICU patients

NCT ID NCT07362862

First seen Jan 23, 2026 · Last updated May 22, 2026 · Updated 18 times

Summary

This study tests a device that sends mild electrical pulses to the thigh muscles of people in the ICU. The goal is to see if it is safe and practical to use, and whether it can slow down muscle weakening. About 50 critically ill patients will either receive standard care or standard care plus daily 60-minute sessions of electrical stimulation. Researchers will monitor muscle strength and any side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEPSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Ascension Seton Medical Center Austin

    NOT_YET_RECRUITING

    Austin, Texas, 78705, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Dell Seton Medical Center at The University of Texas

    NOT_YET_RECRUITING

    Austin, Texas, 78701, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Mayo Clinic

    RECRUITING

    Rochester, Minnesota, 55905, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.